# @drshrum on Instagram

- **Type:** Image
- **Original URL:** https://www.instagram.com/p/DY3aG8eliKA
- **Gondola URL:** https://gondola.cc/posts/66092992-drshrum-instagram
- **Thumbnail:** https://img.gondola.cc/tr:w-,h-,fo-auto/postThumbnails/d9c947513b.jpg
- **Posted:** 2026-05-28T02:34:32.000+00:00
- **Account Owner:** Dr. Kayse Shrum (@drshrum) — https://gondola.cc/drshrum

## Caption

🌿Wellness Wednesday: Peptides Part 3

There is a LOT of discussion right now around Retatrutide — and not just because of the remarkable weight loss data.

Retatrutide is a triple agonist, meaning it targets:

* GLP-1
* GIP
* Glucagon receptors

In early trials, it has shown weight loss approaching bariatric surgery levels in some patients. 

But behind the scenes, there is another major battle happening:
How should Retatrutide be classified?

Eli Lilly and Company has been arguing that Retatrutide should potentially be classified as a biologic rather than a traditional peptide drug. 

Why does that matter?

Because biologics are regulated differently than standard drugs:

* Longer exclusivity protections
* Different manufacturing standards
* More restrictions on compounding
* Greater barriers to generic or copycat competition

In simple terms:
If Retatrutide ultimately receives biologic-type protection, it could significantly limit future compounding and keep costs very high for patients. 

That is why this conversation matters to the general public.

For patients, this debate is really about:

* Access
* Affordability
* Safety
* Innovation
* And who controls the future of these therapies

Supporters of Lilly’s position argue:

* these are highly complex molecules,
* manufacturing consistency matters,
* and stricter oversight protects patients.

Critics argue:

* biologic-style protections may reduce affordability,
* limit access,
* and prevent compounded alternatives that many patients rely on during shortages or due to cost.

The FDA has not made a final determination, and legal challenges are still ongoing. 

#wellnesswednesday  #knowledgeispower

## Stats

- **Views:** 0
- **Likes:** 155
- **Shares:** 0
- **Comments:** 1

## Tags

wellnesswednesday, knowledgeispower

---
Copyright (c) Gondola